Emergent Biosolutions (EBS) Surpasses Q1 Earnings and Revenue EstimatesZacks Investment Research • 04/30/20
Johnson & Johnson Taps Emergent BioSolutions to Help Manufacture Its COVID-19 VaccineThe Motley Fool • 04/24/20
Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19GlobeNewsWire • 04/23/20
Will Emergent Biosolutions (EBS) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 04/23/20
Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public AffairsGlobeNewsWire • 04/06/20
Emergent BioSolutions gets $14.5M in federal funding to expedite COVID-19 plasma therapy developmentTechCrunch • 04/03/20
Emergent BioSolutions Partners with U.S. Government for Comprehensive Response to Expedite Development of Plasma-Derived Therapy for COVID-19GlobeNewsWire • 04/02/20
Why Is Emergent Biosolutions (EBS) Down 23.6% Since Last Earnings Report?Zacks Investment Research • 03/21/20
EMERGENT BIOSOLUTIONS SIGNS DEVELOPMENT AND MANUFACTURING AGREEMENT WITH VAXART FOR THEIR EXPERIMENTAL ORAL VACCINE CANDIDATE FOR CORONAVIRUS DISEASEGlobeNewsWire • 03/18/20
Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus DiseaseGlobeNewsWire • 03/11/20
Teladoc, Ping Identity, Emergent Biosolutions: Portfolio Manager Shares Stock Picks After Monday's CarnageBenzinga • 03/10/20